CYP3A43 activators belong to a class of chemical compounds designed to interact with and modulate the activity of the Cytochrome P450 3A43 enzyme, also known as CYP3A43. Cytochrome P450 (CYP) enzymes are a superfamily of heme-containing proteins that play a crucial role in the metabolism of various endogenous and exogenous compounds in the human body. CYP3A43 is a specific member of the CYP3A subfamily, which is primarily expressed in the liver and is involved in the oxidative metabolism of a wide range of drugs, xenobiotics, and endogenous molecules, including steroids and fatty acids. Activators targeting CYP3A43 are designed to influence its enzymatic activity, affecting the rate and efficiency of metabolic reactions mediated by this enzyme.
The mechanism of action of CYP3A43 activators typically involves their interaction with the CYP3A43 protein, often binding to specific sites or regions within the enzyme's structure. By binding to CYP3A43, these compounds can either enhance or inhibit its enzymatic activity, thereby influencing the metabolism of its substrates. This modulation can lead to changes in the pharmacokinetics of drugs, altering their bioavailability, clearance, and interactions. Researchers are actively investigating the molecular details of CYP3A43 activation and its downstream effects to gain a deeper understanding of its role in drug metabolism and the broader context of xenobiotic and endogenous molecule processing in the human body.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Carbamazepine | 298-46-4 | sc-202518 sc-202518A | 1 g 5 g | $32.00 $70.00 | 5 | |
Carbamazepine induces CYP3A enzymes by activation of nuclear receptors, including PXR and CAR. | ||||||
Efavirenz | 154598-52-4 | sc-207612 | 10 mg | $168.00 | 3 | |
Efavirenz induces CYP3A enzymes, possibly through nuclear receptor-mediated mechanisms. | ||||||
Nevirapine | 129618-40-2 | sc-208092 | 5 mg | $97.00 | 5 | |
Nevirapine is known to induce CYP3A enzymes, potentially through nuclear receptor pathways. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
Pioglitazone can induce CYP3A enzymes, likely involving PPAR-gamma activation. | ||||||
Clotrimazole | 23593-75-1 | sc-3583 sc-3583A | 100 mg 1 g | $41.00 $56.00 | 6 | |
Clotrimazole induces CYP3A enzymes, though the exact mechanism is not fully elucidated. | ||||||
Troglitazone | 97322-87-7 | sc-200904 sc-200904B sc-200904A | 5 mg 10 mg 25 mg | $108.00 $200.00 $426.00 | 9 | |
Troglitazone is known to induce CYP3A enzymes, potentially through PPAR-gamma mediated pathways. | ||||||
Prednisone | 53-03-2 | sc-205816 sc-205816A sc-205816B | 1 g 5 g 25 g | $41.00 $133.00 $663.00 | 2 | |
Prednisone can increase CYP3A enzyme activity, likely through glucocorticoid receptor-mediated effects. | ||||||